{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:58:56Z","timestamp":1794563936613,"version":"4.9.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union-Next generation","id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"EU-NRRP"},{"name":"\u2018Enhancement and strengthening of biomedical research in the NHS"},{"name":"\u2019","award":["PNRR-MR1-2022-12375693"],"award-info":[{"award-number":["PNRR-MR1-2022-12375693"]}]},{"name":"\u2019","award":["I93C22000560006"],"award-info":[{"award-number":["I93C22000560006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Eosinophilic myocarditis (EM) is a rare inflammatory heart disease often associated with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome. While anti\u2013IL-5\/5R and anti\u2013IL-4\/13 monoclonal antibodies (mAbs) efficacy in systemic eosinophilic diseases is established, data on EM are lacking. We aimed to (1) characterize a single-centre cohort of EM patients treated with mepolizumab, benralizumab, or dupilumab in combination with glucocorticoids and\/or immunosuppressants; (2) systematically review published cases, comparing them with a contemporary cohort; and (3) evaluate myocardial response and safety of mAbs in EM, in comparison with a historical cohort treated without mAbs at our centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Thirty-seven EM patients were included (19 from a contemporary cohort, 18 from the literature; 51% male; median age 47 years). Biologic treatments were mepolizumab (81%), benralizumab (14%), and dupilumab (5%). Median time to mAb initiation was 2.5 months; treatment duration 24 months. No EM relapses, deaths, or heart transplantations occurred. Glucocorticoids were tapered and withdrawn in 89% of cases, with no mAb discontinuations due to adverse events. In the contemporary cohort, mAb therapy was associated with improved LVEF (47%\u201355%, P = 0.004), TnI normalization (95%\u201312%, P &amp;lt; 0.001), and eosinophil reduction (95%\u201311%, P &amp;lt; 0.001). Compared with EM patients managed with conventional immunosuppressants alone, the mAb group had no myocarditis relapses (0% vs. 25%) and lower follow-up eosinophil counts (0.04 \u00d7 109\/L vs. 0.85 \u00d7 109\/L).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In EM within eosinophilic disease, anti\u2013IL-5\/5R and anti\u2013IL-4\/13 mAbs showed steroid-sparing effects and favourable safety, suggesting potential benefit for disease control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvag025","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:23:43Z","timestamp":1776684223000},"page":"320-330","source":"Crossref","is-referenced-by-count":3,"title":["Monoclonal antibodies targeting IL-5\/5R or IL-4\/13 pathways in eosinophilic myocarditis: a single-centre experience and systematic literature review"],"prefix":"10.1093","volume":"12","author":[{"given":"Andrea S","family":"Giordani","sequence":"first","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Menghi","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baritussio","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Scognamiglio","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vicenzetto","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Davanzo","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Medicine, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iorio","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Medicine, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Marcolongo","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Gaspari","sequence":"additional","affiliation":[{"name":"Cardiovascular Pathology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Cardiovascular Pathology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-9753","authenticated-orcid":false,"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[{"name":"Cardiovascular Pathology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-375X","authenticated-orcid":false,"given":"Roberto","family":"Padoan","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Medicine, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4901-5655","authenticated-orcid":false,"given":"Alida L P","family":"Caforio","sequence":"additional","affiliation":[{"name":"Cardiology and Cardioimmunology Laboratory, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova , Via Giustiniani 2, Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026071411415481400_pvag025-B1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.23736\/S2724-5683.23.06297-X","article-title":"Eosinophilic myocarditis: from etiology to diagnostics and therapy","volume":"72","author":"Russo","year":"2024","journal-title":"Minerva Cardiol Angiol"},{"key":"2026071411415481400_pvag025-B2","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026071411415481400_pvag025-B3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026071411415481400_pvag025-B4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2019.04.063","article-title":"Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction","volume":"74","author":"Ammirati","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026071411415481400_pvag025-B5","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2026071411415481400_pvag025-B6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026071411415481400_pvag025-B7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02481750","article-title":"Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens","volume":"14","author":"Hayashi","year":"1999","journal-title":"Heart Vessels"},{"key":"2026071411415481400_pvag025-B8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjms.2017.04.002","article-title":"Eosinophilic myocarditis","volume":"354","author":"Cheung","year":"2017","journal-title":"Am J Med Sci"},{"key":"2026071411415481400_pvag025-B9","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/rheumatology\/keae554","article-title":"Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis","volume":"64","author":"Padoan","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026071411415481400_pvag025-B10","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2581812","article-title":"Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience","volume":"57","author":"Davanzo","year":"2025","journal-title":"Ann Med"},{"key":"2026071411415481400_pvag025-B11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"2026071411415481400_pvag025-B12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026071411415481400_pvag025-B13","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026071411415481400_pvag025-B14","first-page":"13","article-title":"Phenotypic characterisation of cellular infiltrates in endomyocardial biopsies of heart transplant recipients with diagnosed steroid resistant cellular rejection","volume":"8","author":"Zakliczy\u0144ski","year":"2003","journal-title":"Ann Transplant"},{"key":"2026071411415481400_pvag025-B15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026071411415481400_pvag025-B16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2026071411415481400_pvag025-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08916930701619235","article-title":"Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy","volume":"41","author":"Caforio","year":"2008","journal-title":"Autoimmunity"},{"key":"2026071411415481400_pvag025-B18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026071411415481400_pvag025-B19","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026071411415481400_pvag025-B20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jclinepi.2017.12.004","article-title":"Recommendations for assessing the risk of bias in systematic reviews of health-care interventions","volume":"97","author":"Viswanathan","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"2026071411415481400_pvag025-B21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13223-021-00639-x","article-title":"Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi","volume":"18","author":"Adachi","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2026071411415481400_pvag025-B22","first-page":"834","article-title":"Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis","volume":"40","author":"Belfeki","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026071411415481400_pvag025-B23","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.jaccas.2020.07.046","article-title":"Allergy and the heart: eosinophilic myocarditis with biventricular thrombi","volume":"2","author":"Buchanan","year":"2020","journal-title":"JACC Case Rep"},{"key":"2026071411415481400_pvag025-B24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.alit.2020.03.001","article-title":"Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis","volume":"69","author":"Colantuono","year":"2020","journal-title":"Allergol Int"},{"key":"2026071411415481400_pvag025-B25","first-page":"100","article-title":"Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma","volume":"28","author":"Goyack","year":"2023","journal-title":"J Cardiol Cases"},{"key":"2026071411415481400_pvag025-B26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/mrcr\/rxab022","article-title":"Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis","volume":"6","author":"Higashitani","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"2026071411415481400_pvag025-B27","article-title":"A unique case report of relapsing eosinophilic myocarditis causing atrial myopathy and persistent sinus arrest","volume":"6","author":"Huynh","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"2026071411415481400_pvag025-B28","article-title":"Eosinophilic endomyocarditis after COVID-19 infection in a heart transplant recipient","volume":"29","author":"Inglis","year":"2024","journal-title":"JACC Case Rep"},{"key":"2026071411415481400_pvag025-B29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ggi.14329","article-title":"Successful treatment of an elderly patient with severe eosinophilic asthma and eosinophilic myocarditis using benralizumab","volume":"22","author":"Kodaka","year":"2022","journal-title":"Geriatr Gerontol Int"},{"key":"2026071411415481400_pvag025-B30","first-page":"45","article-title":"Eosinophilic granulomatosis with polyangiitis in an 8-year-old girl manifesting as hypereosinophilic syndrome with myocarditis, stroke, and subsequent orbital involvement","volume":"30","author":"Panina","year":"2023","journal-title":"Acta Med Litu"},{"key":"2026071411415481400_pvag025-B31","article-title":"Utility of cardiac magnetic resonance imaging in diagnosing eosinophilic myocarditis in a patient recently recovered from COVID-19: a grand round case report","volume":"7","author":"Rao","year":"2023","journal-title":"Eur Heart J Case Rep"},{"key":"2026071411415481400_pvag025-B32","article-title":"Fulminant eosinophilic myocarditis and refractory ventricular arrhythmias requiring mechanical circulatory support: a case report","volume":"8","author":"Brick","year":"2024","journal-title":"Eur Heart J Case Rep"},{"key":"2026071411415481400_pvag025-B33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.46497\/ArchRheumatol.2023.9823","article-title":"Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis","volume":"38","author":"Ulu","year":"2023","journal-title":"Arch Rheumatol"},{"key":"2026071411415481400_pvag025-B34","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242240","article-title":"Successful mepolizumab treatment for DRESS-induced refractory eosinophilic myocarditis and concurrent thyroiditis","volume":"14","author":"Truong","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2026071411415481400_pvag025-B35","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-218992","article-title":"Therapeutic effect of anti-IL-5 on eosinophilic myocarditis with large pericardial effusion","volume":"2017","author":"Song","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2026071411415481400_pvag025-B36","article-title":"Interleukin-5 antagonist monoclonal antibody therapy improves symptoms and reduces steroid dependence in eosinophilic myocarditis patients","volume":"29","author":"Trovato","year":"2024","journal-title":"JACC Case Rep"},{"key":"2026071411415481400_pvag025-B37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"2026071411415481400_pvag025-B38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ejhf.3220","article-title":"Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: a propensity-weighted study","volume":"26","author":"Caforio","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026071411415481400_pvag025-B39","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ard.2025.06.2131","article-title":"Two-year efficacy and safety of anti-interleukin-5\/receptor therapy for eosinophilic granulomatosis with polyangiitis","volume":"84","author":"Merkel","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026071411415481400_pvag025-B40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/art.43146","article-title":"Long-term safety and efficacy of mepolizumab in eosinophilic granulomatosis with polyangiitis","volume":"77","author":"Wechsler","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"2026071411415481400_pvag025-B41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103398","article-title":"Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): a European real-life retrospective comparative study","volume":"153","author":"Mattioli","year":"2025","journal-title":"J Autoimmun"},{"key":"2026071411415481400_pvag025-B42","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1016\/S2665-9913(23)00243-6","article-title":"Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study","volume":"5","author":"Bettiol","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026071411415481400_pvag025-B43","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"2026071411415481400_pvag025-B44","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jaip.2018.04.033","article-title":"Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome","volume":"6","author":"Kuang","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026071411415481400_pvag025-B45","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N Engl J Med"},{"key":"2026071411415481400_pvag025-B46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.20161702","article-title":"Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy","volume":"214","author":"Diny","year":"2017","journal-title":"J Exp Med"},{"key":"2026071411415481400_pvag025-B47","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.913724","article-title":"The diagnostic challenge of eosinophilic granulomatosis with polyangiitis presenting as acute eosinophilic myocarditis: case report and literature review","volume":"9","author":"Yamamoto","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026071411415481400_pvag025-B48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12968-023-00979-0","article-title":"Cardiac magnetic resonance in histologically proven eosinophilic myocarditis","volume":"25","author":"P\u00f6yh\u00f6nen","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026071411415481400_pvag025-B49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.eurheartj.a015230","article-title":"Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis","volume":"18","author":"Caforio","year":"1997","journal-title":"Eur Heart J"},{"key":"2026071411415481400_pvag025-B50","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3390\/jcm10112476","article-title":"Serum anti-heart and anti-intercalated disk autoantibodies: novel autoimmune markers in cardiac sarcoidosis","volume":"10","author":"Caforio","year":"2021","journal-title":"J Clin Med"},{"key":"2026071411415481400_pvag025-B51","article-title":"Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: frequency, clinical and prognostic correlates","volume":"11","author":"Caforio","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag025\/68120008\/pvag025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/320\/68120008\/pvag025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/320\/68120008\/pvag025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:42:12Z","timestamp":1784043732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/4\/320\/8659717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag025","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,21]]}}}